Up to one-third of patients with status epilepticus will not respond to benzodiazepines. Unfortunately, treatment of benzodiazepine-refractory status epilepticus is not well studied. The longer seizures persist, the worse patients do. In this podcast, we discuss the results of the recently completed ESETT trial that evaluated three anticonvulsant medications for status epilepticus.
You can get CME credit for this episode here!Click here for CME Account Creation Instructions
In this podcast we discuss the pearls and perils of ED mechanical ventilation. What are the numbers you NEED to know! We also discuss...
The heat and humidity have returned to the Northern Hemisphere! Numerous deaths have already been reported due to the extreme heat. In this episode...
In December 2019 a novel coronavirus (now named COVID-19) was identified as responsible for a cluster of pneumonia cases in Wuhan, China. As of...